Lisa W. Goldstone head shot
Faculty Directory

Lisa W. GoldstonePharmD, MS, BCPS, BCPP

Lisa W. GoldstonePharmD, MS, BCPS, BCPP

Associate Professor of Clinical Pharmacy and Director of the Residency Programs

Titus Family Department of Clinical Pharmacy

Lisa Goldstone joined the faculty at USC Mann in June 2017 as an associate professor of clinical pharmacy. She received her doctor of pharmacy from the University of Arizona (UA) in 2007 and became an assistant professor at the UA College of Pharmacy in 2010. She earned her master of science in clinical psychology from Illinois State University in 1996 and worked as a professional counselor with at-risk populations in Arizona prior to becoming a pharmacist. She holds board certification in both psychiatric pharmacy and pharmacotherapy. Goldstone has nearly 25 years of clinical experience working with patients with psychiatric disorders across all age groups in a wide variety of settings, although the majority of her work has been with underserved populations.

Goldstone is actively involved in the American Association of Colleges of Pharmacy as the incoming chair-elect of the Pharmacy Practice Section and is involved with the Section of Pharmacy Educators Advisory Group through the American Society of Health-System Pharmacists. She is also a Past President of the American Association of Psychiatric Pharmacists.  She was the recipient of the Preceptor of the Year Award in 2012 from the UA College of Pharmacy and the Original Research Award from CPNP in 2013.

Areas of Expertise

  • Professional Affairs
  • Pharmacy Residency Training
  • Innovative Teaching Strategies
  • Pharmacy Interventions
  • Psychiatric Disorders
  • Psychiatric Pharmacy
  • Mental Health Wellness
  • Government Affairs
  • Education

    University of Arizona


    Illinois State University


    Drake University


  • Links
  • Research Focus

    Clinical application of pharmacogenomics testing

    Dr. Goldstone’s research interests include the clinical application of pharmacogenomics testing, pharmacy service provision to increase access to care for persons with psychiatric and substance use disorders, trends in substance use and the impact of educational interventions, innovative teaching strategies to improve student pharmacist communication skills and ability to provide care using the pharmacists' patient care process, and resident mental health wellness.

  • Selected Articles

    Depression screening patterns, predictors, and trends among adults without a depression diagnosis in ambulatory settings in the United States

    Psychiatric Services
    Sandipan Bhattacharjee, Lisa Goldstone, Nina Vadiei, Jeannie K Lee, William J Burke

    2018 This study examined national patterns, predictors, and trends in depression screening among adults without a diagnosis of depression in the United States.

    Read More

    Patterns and predictors of depression treatment among stroke survivors with depression in ambulatory settings in the United States

    Journal of Stroke and Cerebrovascular Diseases
    Sandipan Bhattacharjee, David Rhys Axon, Lisa Goldstone, Jeannie K Lee

    2018 Despite the importance of treating depression, little is known regarding the current practice pattern of depression treatment among older adults with stroke and depression. We used national survey data from ambulatory settings to examine the depression treatment patterns and predictors among stroke survivors in the United States (US).

    Read More

    Patterns and Predictors of Depression Treatment among Older Adults with Parkinson’s Disease and Depression in Ambulatory Care Settings in the United States

    Parkinson’s Disease
    Sandipan Bhattacharjee, Nina Vadiei, Lisa Goldstone, Ziyad Alrabiah, Scott J Sherman

    2018 Little is known regarding depression treatment patterns and predictors among older adults with comorbid Parkinson's disease and depression (dPD) in the United States (US). The objective of this study was to assess the patterns and predictors of depression treatment among older adults with dPD in the US. We adopted a cross-sectional study design by pooling multiple-year data (2005–2011) from the National Ambulatory Medical Care Survey (NAMCS) and the outpatient department of the National Hospital Ambulatory Medical Care Survey (NHAMCS). The final study sample consisted of visits by older adults with dPD. Depression treatment was defined as antidepressant use with or without psychotherapy. To identify predictors of depression treatment, multivariate logistic regression analysis was conducted adjusting for predisposing, enabling, and need factors. Individuals with dPD and polypharmacy were 74% more likely to receive depression treatment (odds ratio = 1.743, 95% CI 1.376–2.209), while dPD subjects with comorbid chronic conditions were 44% less likely (odds ratio = 0.559, 95% CI 0.396–0.790) to receive depression treatment. Approximately six out of ten older adults with PD and depression received depression treatment. Treatment options for dPD are underutilized in routine clinical practice, and further research should explore how overall medical complexity presents a barrier to depression treatment.

    Read More

    Curriculum in psychiatry and neurology for pharmacy programs

    American Journal of Pharmaceutical Education
    Julie A Dopheide, Jolene R Bostwick, Lisa W Goldstone, Kelan Thomas, Ruth Nemire, Kelly N Gable, Marshall Cates, Joshua Caballero, Tawny Smith, Jacquelyn Bainbridge

    2017 To describe pharmacy curricula in psychiatry and neurology and to report on neuropsychiatric pharmacy specialists’ views on optimal curriculum.

    Read More

    Depression treatment among adults with multiple sclerosis and depression in ambulatory care settings in the United States

    Multiple Sclerosis International
    Sandipan Bhattacharjee, Lisa Goldstone, Queeny Ip, Terri Warholak

    2017 There is little information regarding depression treatment patterns among adults with MS and depression in ambulatory settings at national level in the United States (US).

    Read More

    Improving medication-related outcomes for patients with psychiatric and neurologic disorders: Value of psychiatric pharmacists as part of the health care team.

    Mental Health Clinician
    Lisa W. Goldstone, Bethany A. DiPaula, Joshua Caballero, Susie H. Park, Cristofer Price, and Magdalena Zasadzki Slater

    2015 Psychiatric pharmacists have specialized knowledge, skills, and training or substantial experience working with patients with psychiatric or neurologic disorders. As part of the collaborative team with a physician, psychiatric pharmacists can provide comprehensive medication management (CMM), a direct patient care service, to patients with psychiatric or neurologic disorders.

    Read More

  • Affiliations
    • Myriad Counseling and Consulting, LLC

    • University of Arizona

    • Carondelet Health Network

    • Horizon Human Services

    • Valley Vocational Services

  • Accomplishments

    President, College of Psychiatric and Neurologic Pharmacists (CPNP)


  • Multimedia
    • Lisa W. Goldstone, PharmD, MS, BCPS, BCPP
  • Selected Media Appearances

    Goldstone Takes Office as President of the College of Psychiatric and Neurologic Pharmacists

    USC School of Pharmacy | 08/01/2019

    Associate Professor Lisa W. Goldstone took office as president of the College of Psychiatric and Neurologic Pharmacists (CPNP) on July 1, 2019. She assumed the post of president-elect effective July 1, 2018.

    Read More

    Challenging stigma in mental health care: The power of compassion in your community

    Pharmacy Today | 06/01/2017

    Kelly N. Gable, PharmD, BCPP, associate professor and coordinator of global partnerships at Southern Illinois University Edwardsville School of Pharmacy, and Lisa Goldstone, PharmD, MS, LPC, BCPS, BCPP, associate professor of clinical pharmacy at University of Southern California School of Pharmacy in Los Angeles, have some practical tips for community pharmacists who serve patients with mental illnesses.

    Read More

    How Pharmacists Can Correct Mental Illness Misconceptions

    Pharmacy Today | 10/09/2015

    “Violence and mental illness have become linked in many minds,” Dr. Goldstone told Pharmacy Times. “While there’s some increasing acceptance of disorders such as depression or anxiety due to greater awareness, there’s still a lot of stigma surrounding illnesses like schizophrenia and substance-use disorders.”

    Read More